首页 | 本学科首页   官方微博 | 高级检索  
     

前列地尔联合甲钴胺治疗48例糖尿病神经病变的Il缶床分析
引用本文:彭文导. 前列地尔联合甲钴胺治疗48例糖尿病神经病变的Il缶床分析[J]. 中国实用医药, 2013, 0(11): 156-157
作者姓名:彭文导
作者单位:广东省揭西县人民医院药剂科,515400
摘    要:目的评价前列地尔联合甲钴胺治疗糖尿病神经病变的疗效。方法96例糖尿病神经病变患者,随机分成观察组和对照组两组。对照组给予前列地尔治疗,观察组给予前列地尔联合甲钴胺治疗。结果观察组总有效率87.50%高于对照组70.83%,差异有统计学意义(P〈0.05)。结论前列地尔联合甲钴胺治疗糖尿病神经病变患者疗效可靠。

关 键 词:前列地尔  甲钻胺  糖尿病神经病变

Clinical analysis of alprostadil combined with methylcobalamin treatment of 48 cases of diabetic neuropathy
PENG Wen-dao. Clinical analysis of alprostadil combined with methylcobalamin treatment of 48 cases of diabetic neuropathy[J]. China Practical Medical, 2013, 0(11): 156-157
Authors:PENG Wen-dao
Affiliation:PENG Wen-dao.( Department of pharmacy, Jiexi County People's Hospital, Guangdong 515400, China )
Abstract:Objective To discuss of the efficacy of alprostadil combined with methylcobalamin treatment of diabetic neuropathy. Methods 96 cases of diabetic neuropathy patients, randomly divided into observation group and control group two groups. The control group received alprostadil treatment, the observation group received alprostadil combined with mecobalamin. Results The observation group the total effective rate was 87.50% higher than 70. 83% in the control group, significant difference (P 〈 0.05 ). Conclusion The curative effect is good that alprostadil combined with Methylcobalamin in treatment of patients with diabetic polyneuropathy.
Keywords:Alprostadil  Mecobalamin  Diabetes neuropathy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号